Author Archives for Lea Scheppke
Treatment for Macular Telangiectasia Type 2
February 8, 2016 1:39 pmCharbel Issa P, Kupitz EH, Heeren TF, Holz FG. Dev Ophthalmol. 2016;55:189-95.
Macular Telangiectasia Type 2 Without Clinically Detectable Vasculopathy
February 8, 2016 1:12 pmGillies MC, Mehta H, Bird AC. JAMA Ophthalmol. 2015 Aug;133(8):951-4.
Progression of Vision Loss in Macular Telangiectasia Type 2
February 8, 2016 1:09 pmHeeren TF, Clemons T, Scholl HP, Bird AC, Holz FG, Charbel Issa P. Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3905-12.
Poor long-term outcome of anti-vascular endothelial growth factor therapy in nonproliferative macular telangiectasia type 2
February 8, 2016 1:07 pmKupitz EH, Heeren TF, Holz FG, Charbel Issa P. Retina. 2015 Dec;35(12):2619-26.
Ranibizumab for macular telangiectasia type 2 in the absence of subretinal neovascularization
February 8, 2016 1:03 pmDo DV, Bressler SB, Cassard SD, Gower EW, Tabandeh H, Jefferys JL, Bressler NM. Retina. 2014 Oct;34(10):2063-71.
Macular telangiectasia type 2 (MacTel) in a 34-year-old patient
February 8, 2016 1:00 pmNicolai H, Wirix M, Spielberg L, Leys A. BMJ Case Rep. 2014 Sep 23;2014. pii: bcr2014204802.
Choroidal thickness in macular telangiectasia type 2
February 8, 2016 12:58 pmChhablani J, Kozak I, Jonnadula GB, Venkata A, Narayanan R, Pappuru RR, Rao PS. Retina. 2014 Sep;34(9):1819-23.
“En face” optical coherence tomography imaging in type 2 idiopathic macular telangiectasia
February 4, 2016 1:36 pmWolff B, Basdekidou C, Vasseur V, Sahel JA, Gaudric A, Mauget-Faÿsse M. Retina. 2014 Oct;34(10):2072-8.
Multimodal imaging in type 2 idiopathic macular telangiectasia
February 4, 2016 1:33 pmSallo FB, Leung I, Clemons TE, Peto T, Bird AC, Pauleikhoff D. Retina. 2015 Apr;35(4):742-9.
